Difficulty: Medium
Average Score: 69%
Testbank
A patient's partner, who is a chemist, asks a nurse how serotonin reuptake inhibitors (SSRIs) lift depression. What response will the nurse provide?
Correct answer
B
Rationale
SSRIs make more serotonin available at the synaptic gap.
By inhibiting the reuptake of serotonin into the presynaptic neuron, SSRIs increase the concentration of serotonin in the synaptic cleft, enhancing neurotransmission and improving mood in individuals suffering from depression. This mechanism directly addresses the underlying neurochemical imbalance often associated with depressive disorders.
A: Destroys increased amounts of neurotransmitters. This option misrepresents the function of SSRIs, as they do not destroy neurotransmitters but rather prevent their reabsorption, thereby increasing their availability.
C: Increases production of acetylcholine and dopamine. This choice is incorrect because SSRIs specifically target serotonin, not acetylcholine or dopamine, which are distinct neurotransmitters with different roles in mood regulation.
D: Blocks muscarinic and ?┬▒??-norepinephrine receptors. This option is misleading, as SSRIs primarily affect serotonin receptors and do not block muscarinic or norepinephrine receptors, which are unrelated to serotonin's reuptake process.
By inhibiting the reuptake of serotonin into the presynaptic neuron, SSRIs increase the concentration of serotonin in the synaptic cleft, enhancing neurotransmission and improving mood in individuals suffering from depression. This mechanism directly addresses the underlying neurochemical imbalance often associated with depressive disorders.
A: Destroys increased amounts of neurotransmitters. This option misrepresents the function of SSRIs, as they do not destroy neurotransmitters but rather prevent their reabsorption, thereby increasing their availability.
C: Increases production of acetylcholine and dopamine. This choice is incorrect because SSRIs specifically target serotonin, not acetylcholine or dopamine, which are distinct neurotransmitters with different roles in mood regulation.
D: Blocks muscarinic and ?┬▒??-norepinephrine receptors. This option is misleading, as SSRIs primarily affect serotonin receptors and do not block muscarinic or norepinephrine receptors, which are unrelated to serotonin's reuptake process.